Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. DROTIN-M 80MG/250MG TABLET is to be taken with food. This will help to avoid stomach upset.
DROTIN-M 80MG/250MG TABLET is a combination of two medicines: Drotaverine and Mefenamic Acid which relieve abdominal pain and cramps. Drotaverine is an anti-spasmodic medicine which relieves contractions (spasms) associated with smooth muscles in the abdomen. Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID). It works by blocking the release of certain chemical messengers that cause abdominal pain and inflammation (swelling).
Taking Mefenamic acid with alcohol increases the risk of stomach bleeding.
WEIGH RISKS VS BENEFITS
DROTIN-M 80MG/250MG TABLET may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of DROTIN-M 80MG/250MG TABLET during lactation. Please consult your doctor.
Do not drive unless you are feeling well. As DROTIN-M 80MG/250MG TABLET may cause vertigo.
DROTIN-M 80MG/250MG TABLET should be used with caution in patients with kidney disease. Dose adjustment of DROTIN-M 80MG/250MG TABLET may be needed. Please consult your doctor. Use of DROTIN-M 80MG/250MG TABLET is not recommended in patients with severe kidney disease.
DROTIN-M 80MG/250MG TABLET should be used with caution in patients with liver disease. Dose adjustment of DROTIN-M 80MG/250MG TABLET may be needed. Please consult your doctor.
Drotin-m is a combination of two medicines: Drotaverine and Mefenamic acid. This medication helps to relieve abdominal pain. Drotaverine relieves muscle spasms associated with smooth muscles in the abdomen. Mefenamic Acid works by blocking the release of certain chemical messengers that cause pain and inflammation (swelling).
Q. Is it safe to use Drotin-m?
Yes, Drotin-m is safe to you in most patients with abdominal pain, however, in some patients, it may cause common side effects like nausea, vomiting, heartburn, diarrhoea, loss of appetite, dryness in the mouth, weakness, sleepiness and other uncommon or rare side effects. Inform your doctor as soon as possible if you experience any persistent problem while taking this medication.
Q. Can I stop taking Drotin-m when my pain is relieved?
Drotin-m is usually used for short-term and can be discontinued when your pain is relieved. However, Drotin-m should be continued if you are advised by your physician to do so.
Q. Can the use of Drotin-m cause nausea and vomiting?
Yes, the use of Drotin-m can cause nausea and vomiting. In case, you experience nausea while taking this medicine, take it with milk, food or with antacids. If you start to experience vomiting, drink plenty of water or other fluids. Try small frequent sips of the liquid. Also, avoid taking fatty or fried foods. Talk to your doctor if you have persistent vomiting and signs of dehydration like less urination with dark coloured and strong-smelling urine. Do not take any other medicines without consulting a doctor.
Q. Can the use of Drotin-m cause dry mouth?
Yes, the use of Drotin-m can cause dry mouth. If you experience dry mouth, drink plenty of water. Take regular sips during the day and keep some water on your bedside at night. You may use lip balm if your lips are also dry. Avoid spicy, salty and acidic foods (like lemons),
Q. Can I take a higher dose of this medicine than recommended?
No, do not take a higher than the recommended dose of Drotin-m as it can lead to increased chances of side effects. If you are experiencing increased severity of pain or the pain is not relieved by the recommended doses, please consult your doctor for re-evaluation.
Q. Does Drotin-m expire?
Yes, Drotin-m does expire. Please check the expiry date written on the pack of this medicine. Do not use Drotin-m after the expiry date.
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.